3C-P
The following information was compiled in October 2025 and is subject to change as new research is conducted and as new information becomes available:
Description: 3C-P (4-propoxy-3,5-dimethoxyamphetamine) is a novel hallucinogen and is classified as a 4-alkoxy-substituted 3,5-dimethoxyamphetamine. 3C-P bears structural resemblance to other substituted amphetamines and mescaline derivatives (e.g., proscaline, mescaline, allylescaline). 3C-P was first identified by our laboratory in May 2025 and confirmed after acquiring standard reference material.
Sample Source: In Collaboration with StreetCheck
Sample Appearance: Colorless capsule containing residue
Pharmacology: 3C-P is reported to be a full agonist at the serotonin 5-HT2A receptor, and has no affinity for the 5-HT1A or the 5HT2B.1
Toxicology: 3C-P has not been detected in toxicology cases to date at the CFSRE.
Drug Materials: 3C-P has been detected in one drug material to date at the CFSRE.
Demographics / Geographics: The drug material originated from New England and 3C-P was identified alongside other synthetic hallucinogens (e.g., 5-MeO-DMT and DMT).
Legal Status: 3C-P is not currently scheduled in the United States.
- Class:
- Hallucinogen
- Appearance:
- Colorless capsule containing residue
- Formula:
- C14H23NO3
- MW:
- 253.3
- [M+]:
- 253
- [M+H]+:
- 254.1751
- IUPAC:
- 1-(3,5-dimethoxy-4-propoxy-phenyl)propan-2-amine
- Report Date:
- October 24, 2025
